Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Iris Goetz"'
Autor:
Johan Burisch, He Zhang, Casey Kar-Chan Choong, David Nelson, April Naegeli, Theresa Gibble, Iris Goetz, Alexander Egeberg
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background & Aims: There are currently no validated claims-based indicators for identifying a worsening of disease in patients with inflammatory bowel disease (IBD). Therefore, we aimed to develop and validate indicators that identify flare-ups of IB
Externí odkaz:
https://doaj.org/article/d676b8225096456e877dea6423fe391b
Autor:
Iris Goetz, Casey Choong, Jennifer Winnie, David R. Nelson, Julie Birt, Virginia Noxon, Helen Varker, Nicole Zimmerman, Joseph Tkacz
Publikováno v:
Current Medical Research and Opinion. 38:1641-1649
To develop a claims-based algorithm identifying systemic lupus erythematosus (SLE) flares using a linked claims-electronic medical record (EMR) dataset. This study was a retrospective analysis of linked administrative claims and EMR data spanning 1 J
BACKGROUND There are a variety of study designs that utilize real-world data. To date, there are limited resources available to aid in the selection and evaluation of these study designs to answer important research and policy questions and different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc666e8bfe8345f2234bab4c877b8ee2
https://doi.org/10.2196/preprints.42876
https://doi.org/10.2196/preprints.42876
Autor:
Daniel, Boateng, Thomas, Kumke, Robin, Vernooij, Iris, Goetz, Anna-Katharina, Meinecke, Charlotte, Steenhuis, Diederick, Grobbee, Mira G P, Zuidgeest
Publikováno v:
Contemporary Clinical Trials. 125:107054
The GetReal Trial Tool is a decision support tool to assess the impact of design choices on generalizability of clinical trials to routine clinical practice, while taking into account the risk of bias, precision, acceptability and operational feasibi
Autor:
Charles Williams, Meghan E. Jones, Jennifer L. Miller, Fady T. Botros, Iris Goetz, Kristin J. Meyers, Nancy Clifford, David H. Manner, Jianfei Jiang, Jack Knorr, Brad Woodward, Brian Dillman
Publikováno v:
Journal of Medical Virology
A nested longitudinal study within theAsymptomatic novel CORonavirus iNFfection study followed participants with positive nasopharyngeal swab to query for development of symptoms and assess duration of positive reverse transcription‐polymerase chai
Autor:
Mira G.P. Zuidgeest, Iris Goetz, Anna-Katharina Meinecke, Daniel Boateng, Elaine A. Irving, Ghislaine J.M. van Thiel, Paco M.J. Welsing, Katrien Oude-Rengerink, Diederick E. Grobbee
Publikováno v:
J Clin Epidemiol
Methodologies incorporating Real World Elements into clinical trial design (also called pragmatic trials) offer an attractive opportunity to assess the effect of a treatment strategy in routine care and as such guide decision making in practice. Upta
Autor:
Iris Goetz, Fady T. Botros, Kristin J. Meyers, Jack Knorr, David H. Manner, Meghan E. Jones, Brad Woodward
Publikováno v:
Journal of Medical Virology
The Asymptomatic novel CORonavirus iNfection (ACORN) study was designed to investigate the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the asymptomatic adult population of the Indianapolis metropolitan area
Autor:
Maarten van Smeden, Paco M J Welsing, Iris Goetz, Katrien Oude Rengerink, Antonio Ciaglia, Sven Trelle, Aliki Taylor, Sue Collier, Laurent Eckert, Matthias Egger, Gaëlle Nachbaur
Publikováno v:
Journal of Clinical Epidemiology, 90, 99. Elsevier USA
Results from pragmatic trials should reflect the comparative treatment effects encountered in patients in real-life clinical practice to guide treatment decisions. Therefore pragmatic trials should focus on outcomes that are relevant to patients, cli
Autor:
Ghislaine J. M. W. van Thiel, Mira G. P. Zuidgeest, Johannes J. M. van Delden, Iris Goetz, Rieke van der Graaf, Shona Kalkman, Diederick E. Grobbee
Publikováno v:
Bioethics. 31:136-143
Pragmatic trials aim to directly inform health care decision-making through the collection of so-called 'real world data' from observations of comparative treatment effects in clinical practice. In order to ensure the applicability and feasibility of
Autor:
David R. Nelson, Theresa Gibble, Johan Burisch, April N. Naegeli, Iris Goetz, He Zhang, Casey Choong, Alexander Egeberg
Publikováno v:
Burisch, J, Zhang, H, Choong, C K C, Nelson, D, Naegeli, A, Gibble, T, Goetz, I & Egeberg, A 2021, ' Validation of claims-based indicators used to identify flare-ups in inflammatory bowel disease ', Therapeutic Advances in Gastroenterology, vol. 14 . https://doi.org/10.1177/17562848211004841
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Therapeutic Advances in Gastroenterology
Background & Aims: There are currently no validated claims-based indicators for identifying a worsening of disease in patients with inflammatory bowel disease (IBD). Therefore, we aimed to develop and validate indicators that identify flare-ups of IB